# Code Stroke â€“ Acute Ischemic Stroke with Virtua Voorhees Addenda
## TNK-Optimized Protocol

**Primary Guideline:** American Heart Association/American Stroke Association (AHA/ASA) 2019 Guidelines for Early Management of Acute Ischemic Stroke
**Official Source:** https://www.ahajournals.org/doi/10.1161/STR.0000000000000211
**TNK FDA Approval:** March 2025 - First new stroke medication approved in nearly 30 years

## ENHANCED MERMAID FLOWCHART ALGORITHM

~~~mermaid
graph TD
    A["Code Stroke Activated<br/>NIHSS Assessment + Teleneurology"] --> B["CT Head STAT<br/>&lt;25 minutes"]
    
    B --> C{"Hemorrhage<br/>on CT?"}
    
    C -->|YES| D["Hemorrhagic Stroke Protocol<br/>Neurosurgery + BP Control + ICU"]
    C -->|NO| E{"LVO Screening<br/>NIHSS â‰¥6?"}
    
    E -->|YES| F["CTA Brain/Neck<br/>Thrombectomy Planning"]
    E -->|NO| G{"TNK Eligibility<br/>Assessment"}
    
    G -->|ELIGIBLE| H["TNK 0.25mg/kg bolus<br/>5 seconds"]
    G -->|NOT ELIGIBLE| I["Medical Management<br/>ASA + Standard Care"]
    
    F --> J["Stroke Unit Admission<br/>Post-Intervention Care"]
    H --> K["Post-TNK Monitoring<br/>Neuro Checks q15min"]
    I --> J
    
    K --> L{"EVT Candidate<br/>CTA Results?"}
    
    L -->|YES| M["Transfer for EVT<br/>6-24 hour window"]
    L -->|NO| J
    
    M --> J
    J --> N["Disposition Planning<br/>Rehab Assessment"]
    D --> O["ICU Management<br/>ICP Monitoring"]
    
    style A fill:#ffcccc
    style H fill:#fff2cc
    style J fill:#ccffcc
    style D fill:#ffaaaa
    style K fill:#e6ccff
~~~

## STREAMLINED DYNAMIC CARD SYSTEM - TNK OPTIMIZED

### Card 0 â€“ Stroke Alert & NIHSS Assessment (Node A â†’ B)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸš¨ CODE STROKE ACTIVATED                â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â±ï¸ Door-to-needle timer: <60 minutes    â”‚
â”‚ ğŸ¯ TNK advantage: 5-second bolus        â”‚
â”‚                                         â”‚
â”‚ ğŸ“Š NIHSS Assessment required:           â”‚
â”‚ â€¢ Complete 11-item scale promptly       â”‚
â”‚ â€¢ Score 0-42 (higher = more severe)    â”‚
â”‚ â€¢ Mild (1-4), Moderate (5-15), Severe (16+)â”‚
â”‚                                         â”‚
â”‚ ğŸ“ Sevaro Teleneurology: 856-247-3098   â”‚
â”‚ Response time: <45 seconds              â”‚
â”‚                                         â”‚
â”‚ â“ NIHSS completed?                     â”‚
â”‚                                         â”‚
â”‚ ğŸ”˜ YES â†’ CT imaging                     â”‚
â”‚ ğŸ”˜ NO â†’ Complete assessment            â”‚
â”‚                                         â”‚
â”‚ [Next: Based on Selection â–¶]            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 1A â€“ CT Imaging (Node C â†’ D)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ§  CT HEAD - STAT IMAGING               â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ¯ Target: <25 minutes from arrival     â”‚
â”‚                                         â”‚
â”‚ ğŸ” Evaluate for:                        â”‚
â”‚ â€¢ Intracranial hemorrhage (absolute CI) â”‚
â”‚ â€¢ Large hypodensity (>1/3 MCA territory)â”‚
â”‚ â€¢ Mass effect or midline shift          â”‚
â”‚ â€¢ Early signs of infarction             â”‚
â”‚                                         â”‚
â”‚ â“ Hemorrhage on CT?                     â”‚
â”‚                                         â”‚
â”‚ ğŸ”˜ YES â†’ Hemorrhagic stroke protocol    â”‚
â”‚ ğŸ”˜ NO â†’ LVO screening                   â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous] [Next: Based on Selection â–¶]â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 1B â€“ Hemorrhagic Stroke (Node D - Final)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ©¸ HEMORRHAGIC STROKE MANAGEMENT        â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸš¨ Immediate actions:                   â”‚
â”‚ â€¢ STAT neurosurgery consult            â”‚
â”‚ â€¢ BP management <160/90 (ICH)          â”‚
â”‚ â€¢ Reversal agents if on anticoagulants â”‚
â”‚ â€¢ ICP monitoring consideration          â”‚
â”‚ â€¢ AVOID all thrombolytics              â”‚
â”‚                                         â”‚
â”‚ ğŸ¥ ICU management required              â”‚
â”‚                                         â”‚
â”‚ âœ… HEMORRHAGIC PROTOCOL ACTIVE         â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: CT Imaging]               â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 2A â€“ LVO Screening (Node E)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ” LARGE VESSEL OCCLUSION SCREENING     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ¯ High-risk indicators:                â”‚
â”‚ â€¢ NIHSS â‰¥6                             â”‚
â”‚ â€¢ Gaze deviation (NIHSS item 2 â‰¥1)     â”‚
â”‚ â€¢ Dense hemiparesis (NIHSS 5-6 â‰¥2)     â”‚
â”‚ â€¢ Aphasia (NIHSS item 9 â‰¥1)            â”‚
â”‚ â€¢ Neglect/extinction (NIHSS item 11 â‰¥1)â”‚
â”‚                                         â”‚
â”‚ ğŸ’¡ TNK particularly effective for LVO   â”‚
â”‚                                         â”‚
â”‚ â“ NIHSS â‰¥6 or LVO suspected?           â”‚
â”‚                                         â”‚
â”‚ ğŸ”˜ YES â†’ Order CTA brain/neck          â”‚
â”‚ ğŸ”˜ NO â†’ TNK eligibility assessment     â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous] [Next: Based on Selection â–¶]â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 2B â€“ TNK Eligibility (Node G)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ’‰ TENECTEPLASE ELIGIBILITY             â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ âœ… Inclusion criteria:                  â”‚
â”‚ â€¢ Onset <4.5 hours (last known well)   â”‚
â”‚ â€¢ Age â‰¥18 years                        â”‚
â”‚ â€¢ Measurable neurologic deficit        â”‚
â”‚ â€¢ NIHSS potentially disabling (â‰¥2)     â”‚
â”‚                                         â”‚
â”‚ âŒ Key exclusions:                      â”‚
â”‚ â€¢ Prior ICH, recent stroke <3mo        â”‚
â”‚ â€¢ BP >185/110 refractory to treatment  â”‚
â”‚ â€¢ Active bleeding, recent major surgery â”‚
â”‚ â€¢ INR >1.7, platelets <100,000        â”‚
â”‚ â€¢ Recent anticoagulation               â”‚
â”‚                                         â”‚
â”‚ â“ TNK eligible?                        â”‚
â”‚                                         â”‚
â”‚ ğŸ”˜ YES â†’ Administer TNK                â”‚
â”‚ ğŸ”˜ NO â†’ Medical management             â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous] [Next: Based on Selection â–¶]â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 3A â€“ CTA & Thrombectomy Planning (Node F â†’ Stroke Unit)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ¥ CTA & MECHANICAL THROMBECTOMY        â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ“¸ CTA findings to evaluate:            â”‚
â”‚ â€¢ Large vessel occlusion confirmed     â”‚
â”‚ â€¢ ICA, M1/M2 MCA, basilar artery       â”‚
â”‚ â€¢ Collateral circulation assessment    â”‚
â”‚                                         â”‚
â”‚ ğŸ¯ EVT + TNK bridging criteria:         â”‚
â”‚ â€¢ Pre-stroke mRS 0-2                   â”‚
â”‚ â€¢ ASPECTS score â‰¥6                     â”‚
â”‚ â€¢ Within 6-24 hour window              â”‚
â”‚                                         â”‚
â”‚ ğŸ’¡ TNK preferred for bridging therapy   â”‚
â”‚                                         â”‚
â”‚ [Next: Stroke unit admission â–¶]        â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: LVO Screening]            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 3B â€“ TNK Administration (Node H â†’ Post-TNK)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ’‰ TENECTEPLASE ADMINISTRATION          â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ’Š TNK Protocol (FDA-approved 2025):    â”‚
â”‚ â€¢ Dose: 0.25 mg/kg IV bolus (max 25mg) â”‚
â”‚ â€¢ Single 5-second bolus injection      â”‚
â”‚ â€¢ Dedicated IV line, flush after       â”‚
â”‚ â€¢ No infusion required (vs 60min alteplase)â”‚
â”‚                                         â”‚
â”‚ ğŸš« Hold for 24 hours:                  â”‚
â”‚ â€¢ Anticoagulants, antiplatelets        â”‚
â”‚ â€¢ Avoid arterial punctures             â”‚
â”‚ â€¢ No NG tubes, foley catheters         â”‚
â”‚                                         â”‚
â”‚ âš¡ Advantages over alteplase:            â”‚
â”‚ â€¢ Faster administration                â”‚
â”‚ â€¢ No infusion delays                   â”‚
â”‚ â€¢ Better for transport/transfers        â”‚
â”‚                                         â”‚
â”‚ [Next: Post-TNK monitoring â–¶]          â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: TNK Eligibility]          â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 3C â€“ Medical Management (Node I â†’ Stroke Unit)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ’Š MEDICAL MANAGEMENT                   â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ¯ Standard stroke care:                â”‚
â”‚ â€¢ ASA 325mg (after 24h if TNK given)   â”‚
â”‚ â€¢ BP management <220/120 (no thrombolytics)â”‚
â”‚ â€¢ Glucose 140-180 mg/dL                â”‚
â”‚ â€¢ Temperature <38Â°C                     â”‚
â”‚ â€¢ DVT prophylaxis                      â”‚
â”‚                                         â”‚
â”‚ ğŸ“Š Monitor for:                         â”‚
â”‚ â€¢ Neurological deterioration           â”‚
â”‚ â€¢ Swallowing dysfunction               â”‚
â”‚ â€¢ Complications                        â”‚
â”‚                                         â”‚
â”‚ [Next: Stroke unit admission â–¶]        â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: TNK Eligibility]          â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 4A â€“ Post-TNK Monitoring (Node K)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ‘ï¸ POST-TENECTEPLASE MONITORING         â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â±ï¸ Neurologic checks (AHA protocol):    â”‚
â”‚ â€¢ Q15min Ã— 2 hours                     â”‚
â”‚ â€¢ Q30min Ã— 6 hours                     â”‚
â”‚ â€¢ Q1h Ã— 16 hours                       â”‚
â”‚                                         â”‚
â”‚ ğŸš¨ Alert criteria (same as alteplase):  â”‚
â”‚ â€¢ NIHSS increase â‰¥4 points             â”‚
â”‚ â€¢ New severe headache, N/V             â”‚
â”‚ â€¢ BP >180/105 refractory               â”‚
â”‚ â€¢ Signs of systemic bleeding           â”‚
â”‚                                         â”‚
â”‚ ğŸ’¡ TNK benefits:                        â”‚
â”‚ â€¢ Lower bleeding risk vs alteplase      â”‚
â”‚ â€¢ No infusion to monitor/maintain      â”‚
â”‚                                         â”‚
â”‚ â“ Neurologic deterioration?            â”‚
â”‚                                         â”‚
â”‚ ğŸ”˜ YES â†’ STAT CT, hold antithrombotics â”‚
â”‚ ğŸ”˜ NO â†’ Continue standard monitoring   â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous] [Next: Based on Selection â–¶]â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 5 â€“ Stroke Unit Admission (Node J)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ¥ STROKE UNIT CARE                     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ“‹ Acute management:                    â”‚
â”‚ â€¢ Dedicated stroke unit admission      â”‚
â”‚ â€¢ Swallow screening before PO          â”‚
â”‚ â€¢ Early mobilization (24-48h)          â”‚
â”‚ â€¢ Cardiac monitoring Ã— 24h minimum     â”‚
â”‚                                         â”‚
â”‚ ğŸ’Š Secondary prevention (after 24h):    â”‚
â”‚ â€¢ Antiplatelet: ASA 81mg daily         â”‚
â”‚ â€¢ High-intensity statin: Atorvastatin 80mgâ”‚
â”‚ â€¢ BP optimization per guidelines       â”‚
â”‚ â€¢ Diabetes management if present       â”‚
â”‚                                         â”‚
â”‚ ğŸ”„ Rehabilitation assessments:          â”‚
â”‚ â€¢ PT evaluation and mobility           â”‚
â”‚ â€¢ OT for activities of daily living    â”‚
â”‚ â€¢ Speech therapy for dysphagia/aphasia â”‚
â”‚                                         â”‚
â”‚ â“ EVT candidate?                       â”‚
â”‚                                         â”‚
â”‚ ğŸ”˜ YES â†’ Transfer for thrombectomy     â”‚
â”‚ ğŸ”˜ NO â†’ Continue stroke unit care      â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous] [Next: Based on Selection â–¶]â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 6A â€“ Transfer for EVT (Node M â†’ Final)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸš TRANSFER FOR ENDOVASCULAR THERAPY   â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ¯ EVT criteria confirmed:              â”‚
â”‚ â€¢ Large vessel occlusion on CTA        â”‚
â”‚ â€¢ Within treatment window (6-24h)      â”‚
â”‚ â€¢ Good functional status (mRS 0-2)     â”‚
â”‚ â€¢ ASPECTS â‰¥6                           â”‚
â”‚                                         â”‚
â”‚ ğŸš€ Expedited transfer:                  â”‚
â”‚ â€¢ Direct communication with EVT center â”‚
â”‚ â€¢ Continue medical management          â”‚
â”‚ â€¢ Monitor during transport             â”‚
â”‚                                         â”‚
â”‚ âœ… EVT TRANSFER PROTOCOL ACTIVE        â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: Stroke Unit Care]         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 6B â€“ Disposition Planning (Node N - Final)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ“… STROKE DISCHARGE PLANNING            â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ¯ Discharge criteria:                  â”‚
â”‚ â€¢ Neurologically stable â‰¥24 hours      â”‚
â”‚ â€¢ Safe swallow or alternative nutrition â”‚
â”‚ â€¢ Ambulation or appropriate equipment   â”‚
â”‚ â€¢ Secondary prevention medications      â”‚
â”‚                                         â”‚
â”‚ ğŸ  Disposition options:                 â”‚
â”‚ â€¢ Home with outpatient therapy         â”‚
â”‚ â€¢ Home with home health services       â”‚
â”‚ â€¢ Acute rehabilitation facility        â”‚
â”‚ â€¢ Skilled nursing facility             â”‚
â”‚                                         â”‚
â”‚ ğŸ“‹ Follow-up appointments:              â”‚
â”‚ â€¢ Neurology: 1-2 weeks                 â”‚
â”‚ â€¢ Primary care: 1 week                 â”‚
â”‚ â€¢ Rehabilitation services as needed    â”‚
â”‚                                         â”‚
â”‚ âœ… STROKE PROTOCOL
